Atalay P, Ozpolat B
Cancers (Basel). 2024; 16(3).
PMID: 38339286
PMC: 10854964.
DOI: 10.3390/cancers16030535.
Cho H, Lee J, Yoon S, Lee H, Jung H
Int J Mol Sci. 2020; 21(13).
PMID: 32640596
PMC: 7369689.
DOI: 10.3390/ijms21134780.
Broutian T, Jiang B, Li J, Akagi K, Gui S, Zhou Z
Cancer Lett. 2020; 476:23-33.
PMID: 31958486
PMC: 7239795.
DOI: 10.1016/j.canlet.2020.01.012.
Mazzacurati L, Collins R, Pandey G, Lambert-Showers Q, Amin N, Zhang L
Blood Adv. 2019; 3(22):3503-3514.
PMID: 31725895
PMC: 6880903.
DOI: 10.1182/bloodadvances.2019000260.
Liu Z, Liu H, Yuan X, Wang Y, Li L, Wang G
Oncol Lett. 2018; 15(4):4079-4086.
PMID: 29541172
PMC: 5835926.
DOI: 10.3892/ol.2018.7865.
Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?.
Amin A, Peters T, Li L, Sundara Rajan S, Choudhari R, Puvvada S
Cold Spring Harb Mol Case Stud. 2017; 3(3):a001719.
PMID: 28487884
PMC: 5411687.
DOI: 10.1101/mcs.a001719.
Upregulation of PIM2 by Underexpression of MicroRNA-135-5p Improves Survival Rates of Skin Allografts by Suppressing Apoptosis of Fibroblast Cells.
Zhang H
Med Sci Monit. 2017; 23:107-113.
PMID: 28064305
PMC: 5240881.
DOI: 10.12659/msm.897613.
Pim1 kinase regulates c-Kit gene translation.
An N, Cen B, Cai H, Song J, Kraft A, Kang Y
Exp Hematol Oncol. 2017; 5:31.
PMID: 28042518
PMC: 5200960.
DOI: 10.1186/s40164-016-0060-3.
Control of translational activation by PIM kinase in activated B-cell diffuse large B-cell lymphoma confers sensitivity to inhibition by PIM447.
Peters T, Li L, Tula-Sanchez A, Pongtornpipat P, Schatz J
Oncotarget. 2016; 7(39):63362-63373.
PMID: 27556513
PMC: 5325370.
DOI: 10.18632/oncotarget.11457.
Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
Zhao Y, Yin Y, Liu J, Wang G, Huang J, Zhu L
Acta Pharmacol Sin. 2016; 37(9):1237-50.
PMID: 27397540
PMC: 5022099.
DOI: 10.1038/aps.2016.60.
Characterization of Leukemia-Inducing Genes Using a Proto-Oncogene/Homeobox Gene Retroviral Human cDNA Library in a Mouse In Vivo Model.
Jang S, Lee S, Chung H
PLoS One. 2015; 10(11):e0143240.
PMID: 26606454
PMC: 4659616.
DOI: 10.1371/journal.pone.0143240.
Targeting the Pim kinases in multiple myeloma.
Keane N, Reidy M, Natoni A, Raab M, ODwyer M
Blood Cancer J. 2015; 5:e325.
PMID: 26186558
PMC: 4526774.
DOI: 10.1038/bcj.2015.46.
Pim-2 Kinase Influences Regulatory T Cell Function and Stability by Mediating Foxp3 Protein N-terminal Phosphorylation.
Deng G, Nagai Y, Xiao Y, Li Z, Dai S, Ohtani T
J Biol Chem. 2015; 290(33):20211-20.
PMID: 25987564
PMC: 4536430.
DOI: 10.1074/jbc.M115.638221.
Pathophysiological roles of Pim-3 kinase in pancreatic cancer development and progression.
Li Y, Mukaida N
World J Gastroenterol. 2014; 20(28):9392-404.
PMID: 25071334
PMC: 4110571.
DOI: 10.3748/wjg.v20.i28.9392.
A small-molecule inhibitor of PIM kinases as a potential treatment for urothelial carcinomas.
Foulks J, Carpenter K, Luo B, Xu Y, Senina A, Nix R
Neoplasia. 2014; 16(5):403-12.
PMID: 24953177
PMC: 4198696.
DOI: 10.1016/j.neo.2014.05.004.
Genetic Modeling of PIM Proteins in Cancer: Proviral Tagging and Cooperation with Oncogenes, Tumor Suppressor Genes, and Carcinogens.
Aguirre E, Renner O, Narlik-Grassow M, Blanco-Aparicio C
Front Oncol. 2014; 4:109.
PMID: 24860787
PMC: 4030178.
DOI: 10.3389/fonc.2014.00109.
Serine threonine kinase Pim-3 regulates STAT3 pathway to inhibit proliferation of human liver cancers.
Wang J, Lao L, Zhao H, Huang Y
Int J Clin Exp Med. 2014; 7(2):348-55.
PMID: 24600488
PMC: 3931587.
AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia.
Keeton E, McEachern K, Dillman K, Palakurthi S, Cao Y, Grondine M
Blood. 2013; 123(6):905-13.
PMID: 24363397
PMC: 3916880.
DOI: 10.1182/blood-2013-04-495366.
Pim1 serine/threonine kinase regulates the number and functions of murine hematopoietic stem cells.
An N, Lin Y, Mahajan S, Kellner J, Wang Y, Li Z
Stem Cells. 2013; 31(6):1202-12.
PMID: 23495171
PMC: 3664117.
DOI: 10.1002/stem.1369.
Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice.
An N, Kraft A, Kang Y
J Hematol Oncol. 2013; 6:12.
PMID: 23360755
PMC: 3610283.
DOI: 10.1186/1756-8722-6-12.